Sangui Bio Tech International Inc.
EANS-News: Sangui Bio Tech International Inc.
Continuous trading in Sangui
shares restored in German markets
Additional listing on Berlin stock exchange
--------------------------------------------------------------------------------
Corporate news transmitted by euro adhoc. The issuer/originator is solely
responsible for the content of this announcement.
--------------------------------------------------------------------------------
Financing, Stock Offerings (IPO)
Witten, Germany, March 22, 2012 (euro adhoc) - Continuous trading in Sangui
shares restored in German markets
Additional listing on Berlin stock exchange
As of today, the shares of Sangui BioTech International, Inc. can be traded
continuously again on an additional German stock exchange. Stock broker mwb
Fairtrade AG had applied for a listing on the Berlin stock exchange in addition
to the one auction only trading on the stock Hamburg exchange and the continuous
trading on the OTCQB marketplace. The German share identification number
continues to be 906757.
Sangui BioTech International, Inc. ("SGBI") is a holding company the shares of
which are being traded on the OTCQB marketplace (www.otcmarkets.com: SGBI) and
the OTC market of Hamburg-Hannover and Berlin stock exchanges. Its purpose is to
provide financing and access to the capital markets for the enterprises of the
Sangui group. SanguiBioTech GmbH is a ninety percent subsidiary of Sangui
BioTech International, Inc.
Further inquiry note:
Dr. Joachim Fleing
Fon: +49 (179) 7963472
Fax: +49 (2302) 915191
e-mail: fleing@sangui.de
end of announcement euro adhoc
--------------------------------------------------------------------------------
company: Sangui Bio Tech International Inc.
Alfred-Herrhausen-Strasse 44
D-58455 Witten
phone: +49(0)2302 915-200
FAX: +49(0)2302 915-191
mail: info@sangui.de
WWW: http://www.sanguibiotech.com
sector: Biotechnology
ISIN: DE0000906757, US80105B1017
indexes:
stockmarkets: free trade: Berlin, Hamburg, New York
language: English